Bottom line
CHNA vs IXJ: the short answer
CHNA (Loncar China BioPharma ETF) and IXJ (iShares Global Healthcare ETF) are both etfs.
Updated Nov 19, 2026
CHNA vs IXJ side by side
| CHNA | IXJ | |
|---|---|---|
| Type | ETF | ETF |
| Fund family | Grayscale | iShares |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | — | 0.38% |
| Annual cost per $10k | — | $38 |
| 10-yr cost on $10k (prospectus) | — | $480 |
| Max front load | None | None |
| 12b-1 fee | — | 0% |
| 1-yr return | — | +14.9% |
| 5-yr return (annualized) | — | +6.4% |
| 10-yr return (annualized) | — | +8.2% |
| Best quarter | — | +13.6% |
| Worst quarter | — | −11.8% |
| Net assets (fund) | — | $3.8B |
| Number of holdings | — | 124 |
| Portfolio turnover | — | 2% |
| Returns as of | — | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Holdings overlap
CHNA and IXJ share none of their top holdings.
CHNA top 10
IXJ top 10
- Eli Lilly And Company — 10.93%
- Johnson & Johnson — 7.04%
- Abbvie Inc. — 5.12%
- Unitedhealth Group Incorporated — 4.40%
- Merck & Co., Inc. — 4.12%
- Astrazeneca Plc — 3.76%
- Roche Holding AG — 3.75%
- Novartis AG — 3.71%
- Amgen Inc. — 2.54%
- Thermo Fisher Scientific Incorporated — 2.42%
FAQ
What is the difference between CHNA and IXJ?
CHNA (Loncar China BioPharma ETF) and IXJ (iShares Global Healthcare ETF) are both etfs.
Should I own both CHNA and IXJ?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.